Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2016 1
2018 3
2019 11
2020 12
2021 19
2022 23
2023 11
2024 30
2025 28
2026 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial.
Silva EAD Junior, Medeiros WMB, Santos JPMD, Sousa JMM, Costa FBD, Pontes KM, Borges TC, Espínola C Neto Segundo, Andrade E Silva AH, Nunes ELG, Alves NT, Rosa MDD, Albuquerque KLGD. Silva EAD Junior, et al. Trends Psychiatry Psychother. 2024;46:e20210396. doi: 10.47626/2237-6089-2021-0396. Epub 2022 May 26. Trends Psychiatry Psychother. 2024. PMID: 35617670 Free PMC article. Clinical Trial.
OBJECTIVE: Autism spectrum disorder (ASD) is characterized by persistent deficits in social communication and social interaction and by restricted and repetitive patterns of behavior. ...The objective of this study was to evaluate the efficacy and safety of a …
OBJECTIVE: Autism spectrum disorder (ASD) is characterized by persistent deficits in social communication and social in …
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Pedrazzi JFC, Ferreira FR, Silva-Amaral D, Lima DA, Hallak JEC, Zuardi AW, Del-Bel EA, Guimarães FS, Costa KCM, Campos AC, Crippa ACS, Crippa JAS. Pedrazzi JFC, et al. Psychopharmacology (Berl). 2022 Sep;239(9):2713-2734. doi: 10.1007/s00213-022-06196-4. Epub 2022 Jul 29. Psychopharmacology (Berl). 2022. PMID: 35904579 Review.
RATIONALE: Autism spectrum disorder (ASD) is defined as a group of neurodevelopmental disorders whose symptoms include impaired communication and social interaction, restricted and repetitive patterns of behavior, and varying levels of intellectual disability …
RATIONALE: Autism spectrum disorder (ASD) is defined as a group of neurodevelopmental disorders whose symptoms include …
An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.
Aishworiya R, Valica T, Hagerman R, Restrepo B. Aishworiya R, et al. Neurotherapeutics. 2022 Jan;19(1):248-262. doi: 10.1007/s13311-022-01183-1. Epub 2022 Jan 14. Neurotherapeutics. 2022. PMID: 35029811 Free PMC article. Review.
While behavioral interventions remain the mainstay of treatment of autism spectrum disorder (ASD), several potential targeted treatments addressing the underlying neurophysiology of ASD have emerged in the last few years. ...In this article, we provide a revi …
While behavioral interventions remain the mainstay of treatment of autism spectrum disorder (ASD), several potential ta …
Memantine for autism spectrum disorder.
Brignell A, Marraffa C, Williams K, May T. Brignell A, et al. Cochrane Database Syst Rev. 2022 Aug 25;8(8):CD013845. doi: 10.1002/14651858.CD013845.pub2. Cochrane Database Syst Rev. 2022. PMID: 36006807 Free PMC article.
BACKGROUND: Autism spectrum disorder (ASD; also known as autism) is a developmental disability that begins in childhood and is typically seen in around 1% to 2% of children. ...To confirm the diagnosis, one study used the Autism Diagnostic Obser …
BACKGROUND: Autism spectrum disorder (ASD; also known as autism) is a developmental disability that begins in ch …
Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
Poleg S, Golubchik P, Offen D, Weizman A. Poleg S, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:90-96. doi: 10.1016/j.pnpbp.2018.08.030. Epub 2018 Aug 29. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30171992 Review.
Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social communication, restricted and repetitive patterns of behavior, interests, or activities and often intellectual disabilities. ...There is increasing interest in cannabinoids, espe
Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social communication, restricted and repetiti
Cannabis and cannabinoid use in autism spectrum disorder: a systematic review.
Silva EAD Junior, Medeiros WMB, Torro N, Sousa JMM, Almeida IBCM, Costa FBD, Pontes KM, Nunes ELG, Rosa MDD, Albuquerque KLGD. Silva EAD Junior, et al. Trends Psychiatry Psychother. 2022 Jun 13;44:e20200149. doi: 10.47626/2237-6089-2020-0149. Trends Psychiatry Psychother. 2022. PMID: 34043900 Free PMC article.
INTRODUCTION: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction, associated with the presence of restricted and repetitive patterns of behavior, interests …
INTRODUCTION: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent defici …
Cannabinoid treatment for autism: a proof-of-concept randomized trial.
Aran A, Harel M, Cassuto H, Polyansky L, Schnapp A, Wattad N, Shmueli D, Golan D, Castellanos FX. Aran A, et al. Mol Autism. 2021 Feb 3;12(1):6. doi: 10.1186/s13229-021-00420-2. Mol Autism. 2021. PMID: 33536055 Free PMC article. Clinical Trial.
BACKGROUND: Endocannabinoid dysfunction in animal models of autism spectrum disorder (ASD) and accumulating, albeit anecdotal, evidence for efficacy in humans motivated this placebo-controlled double-blind comparison of two oral cannabinoid solutions in 150 p …
BACKGROUND: Endocannabinoid dysfunction in animal models of autism spectrum disorder (ASD) and accumulating, albeit ane …
State-of-the-art therapies for fragile X syndrome.
Protic D, Hagerman R. Protic D, et al. Dev Med Child Neurol. 2024 Jul;66(7):863-871. doi: 10.1111/dmcn.15885. Epub 2024 Feb 22. Dev Med Child Neurol. 2024. PMID: 38385885 Free PMC article. Review.
Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by a full mutation (> 200 CGG repeats) in the FMR1 gene. FXS is the leading cause of inherited intellectual disabilities and the most commonly known genetic cause of autism spectrum disord
Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by a full mutation (> 200 CGG repeats) in the FMR1 gene. FXS is t …
Atypical antipsychotics for autism spectrum disorder: a network meta-analysis.
Meza N, Franco JV, Sguassero Y, Núñez V, Escobar Liquitay CM, Rees R, Williams K, Rojas V, Rojas F, Pringsheim T, Madrid E. Meza N, et al. Cochrane Database Syst Rev. 2025 May 21;5(5):CD014965. doi: 10.1002/14651858.CD014965.pub2. Cochrane Database Syst Rev. 2025. PMID: 40396498 Free PMC article.
RATIONALE: Individuals with autism spectrum disorder (ASD) exhibit a wide variety of symptoms related to social interaction and behaviour. ...Furthermore, our findings on adults with autism were scarce due to the lack of available studies. AUTHORS' CON …
RATIONALE: Individuals with autism spectrum disorder (ASD) exhibit a wide variety of symptoms related to social interac …
The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review.
Jawed B, Esposito JE, Pulcini R, Zakir SK, Botteghi M, Gaudio F, Savio D, Martinotti C, Martinotti S, Toniato E. Jawed B, et al. Int J Mol Sci. 2024 Nov 20;25(22):12453. doi: 10.3390/ijms252212453. Int J Mol Sci. 2024. PMID: 39596518 Free PMC article.
Autism spectrum disorder (ASD) is a neurological disease and lifelong condition. The treatment gap in ASD has led to growing interest in alternative therapies, particularly in phytocannabinoids, which are naturally present in Cannabis sativa. Studies indicate
Autism spectrum disorder (ASD) is a neurological disease and lifelong condition. The treatment gap in ASD has led to gr
135 results